Anaphylaxis

To ensure that anaphylaxis episodes are treated in a timely and effective manner, action plans should be developed and distributed to patients, family and other caregivers, and schools.

New research indicates that doctors who treat anaphylaxis with intravenous epinephrine rather than intramuscular or subcutaneous injections are increasing the risk that patients will suffer overdoses or other adverse reactions.

Study results indicate BAX326 shows potential and is an efficacious and safe alternative treatment for patients with hemophilia B.

New research suggests that oral immunotherapy may trigger anaphylaxis in an unusually high percentage of asthmatic teenagers with high-risk food allergies who failed to adhere to their management plan.

A new multi-step skin testing protocol effectively determines the presence of isosulfan blue allergy, according to a study conducted by researchers at the University of Virginia.

New research has reached the unexpected conclusion that non-steroidal anti-inflammatory drugs (NSAIDs) may rank among the top causes of drug-induced anaphylaxis.

Comparatively few patients treated for anaphylaxis in the emergency department are prescribed adrenaline autoinjectors, and many who do receive them either do not know how to properly use the device or fail to carry it with them at all times.